Balloon pulmonary angioplasty for lung disease patients to be funded by NHS in the UK

NHS England has stated it will be funding a pioneering procedure that will improve treatment outcomes for patients with a lung disease called Chronic Thromboembolic Pulmonary Hypertension (CTEPH). The condition involves chronic blood clots block blood flow in the arteries, raising pressure in the lung, which can cause heart failure and premature death. Patients with

Continue Reading

CMO Breakfast – The Ivy, London

Only Medics was an acquisition from the talented and innovative Dr Elaine Ford in 2009. In 2012 when I joined Clinical Professionals as Group Managing Director having worked with Elaine for many years previously, the legacy of her brand and driving it forward was a key focus for me. Last year saw Only Medics most

Continue Reading

EMA to review Marketing Authorisation of GW Pharma’s cannibidiol

EMA has accepted GW Pharmaceuticals’ request to review the MMA (Marketing Authorisation Application) of Epidiolex, or cannibidiol. The treatment is currently used on patients who suffer from seizures linked to Lennox-Gastaut syndrome and Dravet syndrome. GW Pharmaceuticals first submitted Epidiolex for review in December 2017. The successful filing of the MAA of the drug follows

Continue Reading

New US study data suggests exercise could increase lifespan after treatment for breast cancer

A new study conducted by researchers from the University of Southern California in Los Angeles, explains how aerobic and resistance exercise can increase life expectancy for patients who have successfully completed breast cancer treatment. According to National Cancer Institute estimates, in 2017 there were approximately 252,710 new diagnoses of breast cancer in the United States.

Continue Reading